Amendment to PAR-03-138 "Novel HIV Therapies: Integrated Preclinical/Clinical Program

Notice Number: NOT-AI-05-035

Key Dates
Release Date: April 12, 2005
Application Receipt Date(s): November 17, 2005
Peer Review Date(s): March, 2006
Council Review Date(s) : May, 2006
Earliest Anticipated Start Date: June 2006
Expiration Date: November 18, 2005

Issued by
National Institute of Allergy and Infectious Diseases (NIAID), (http://www.niaid.nih.gov/)
National Institute of Mental Health (NIMH), (http://www.nimh.nih.gov)

The National Institute of Allergy and Infectious Diseases (NIAID) is amending PAR-03-138, Novel HIV Therapies: Integrated Preclinical/Clinical Program as follows.

The new contact for peer review issues is now:

Dr. Eugene Baizman
Division of Extramural Affairs
National Institute of Allergy and Infectious Diseases
Room Number 3125, MSC-7616
6700-B Rockledge Drive
Bethesda, MD 20892
Telephone: (301) 496-2550
FAX: (301) 402-2638
Email: eb237e@nih.gov

In addition the two extra copies of the application packet and all five sets of appendix material are to be sent to Dr. Baizman.

Inquiries

Direct questions about NIAID scientific/research issues to:

Sandra Bridges, Ph.D.
Division of AIDS
National Institute of Allergy and Infectious Diseases
Room 4128, MSC-7626
6700-B Rockledge Drive
Bethesda, MD 20892-7626
Telephone: (301) 496-8198
FAX: (301) 402-3211
Email: sb33j@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.